People without diabetes can use continuous glucose monitors. But should they? [USA TODAY]
DexCom, Inc. (DXCM)
Last dexcom, inc. earnings: 4/28 04:03 pm
Check Earnings Report
US:NASDAQ Investor Relations:
dexcom.com/investors
Company Research
Source: USA TODAY
Since she was 46, her doctor said, it was likely perimenopause. But when the symptoms worsened, Pinelli knew something was wrong. “It was so stressful trying to convince my doctor,” said Pinelli, of Buffalo, New York. “It felt like, ‘You're not even listening to me.'” Desperate for insight into her symptoms, Pinelli decided on her own to start wearing a continuous glucose monitor. The data from the medical device, typically prescribed to diabetics for monitoring blood sugar, showed she was experiencing episodes of hypoglycemia or low blood sugar. This finding finally got her doctor's attention, prompting further investigation into the confusing symptoms that may have been tied to autoimmune issues. Continuous glucose monitors, or CGMs, have become more accessible since the Food and Drug Administration cleared them for over-the-counter use in March. Pinelli is part of a growing group of people without diabetes who use them as tracking tools to improve their health and wellness.
Show less
Read more
Impact Snapshot
Event Time:
DXCM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DXCM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DXCM alerts
High impacting DexCom, Inc. news events
Weekly update
A roundup of the hottest topics
DXCM
News
- Analyst Cautiously Optimistic On DexCom As Competitive Pressures Loom [Yahoo! Finance]Yahoo! Finance
- DexCom Inc (DXCM) Q4 2024 Earnings Call Highlights: Revenue Growth Amid Margin Challenges [Yahoo! Finance]Yahoo! Finance
- DexCom, Inc. (NASDAQ: DXCM) had its price target raised by analysts at Morgan Stanley from $75.00 to $82.00. They now have an "equal weight" rating on the stock.MarketBeat
- DexCom, Inc. (NASDAQ: DXCM) had its price target raised by analysts at Canaccord Genuity Group Inc. from $99.00 to $103.00. They now have a "buy" rating on the stock.MarketBeat
- DexCom (DXCM) Q4 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
DXCM
Earnings
- 2/13/25 - Miss
DXCM
Sec Filings
- 2/13/25 - Form 8-K
- 1/30/25 - Form 4
- 1/30/25 - Form 4
- DXCM's page on the SEC website